Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligenceJulius Keyl, Jens Kleesiek, Michael Forsting et al.|Nature Cancer|2025Cited by 48
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical TherapyHelena Lanzafame, Wolfgang P. Fendler, Ilektra A. Mavroeidi et al.|Journal of Nuclear Medicine|2024Cited by 36
Diagnostic Accuracy of<sup>68</sup>Ga-FAPI Versus<sup>18</sup>F-FDG PET in Patients with Various MalignanciesNader Hirmas, Wolfgang P. Fendler, Rainer Hamacher et al.|Journal of Nuclear Medicine|2024Cited by 31
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trialKim M. Pabst, Wolfgang P Fendler, Manuel Weber et al.|The Lancet Oncology|2025Cited by 30
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [68Ga]Ga-/[18F]F-PSMA-11/-1007, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET/CT: a pilot studyKim M. Pabst, Wolfgang P. Fendler, Riccardo Mei et al.|European Journal of Nuclear Medicine and Molecular Imaging|2024Cited by 18